Departments of Gynecologic Oncology and Reproductive Medicine, Anesthesiology and Perioperative Medicine, Biostatistics, and Symptom Research, and the Division of Pharmacy, the University of Texas MD Anderson Cancer Center, Houston, Texas; Tennessee Oncology, Nashville, Tennessee; and the University of Tennessee Health Sciences Center, Memphis, Tennessee.
Corresponding author: Larissa A. Meyer, MD, MPH, Department of Gynecologic Oncology and Reproductive Medicine, Unit 1362, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030; email: [email protected].
Larissa A. Meyer is supported by a NIH-NCI K07-CA201013 grant. This work was in part supported through a NIH-NCI P30 CA016672 core grant (Biostatistics Resource Group and Clinical Trials Support Resource).
Financial Disclosure Dr. Meyer has received research funding from AstraZeneca for unrelated research and has participated in an advisory board for Clovis Oncology. The other authors did not report any potential conflicts of interest.
Presented at the World Congress of Enhanced Recovery after Surgery and Perioperative Medicine Annual Meeting, May 9–12, 2015, Washington, DC; the International Meeting of the European Society of Gynaecological Oncology, October 24–27, 2015, Nice, France; and the Society of Gynecologic Oncology Annual Meeting on Women's Cancer, March 19–22, 2016, San Diego, California.
Each author has indicated that he or she has met the journal's requirements for authorship.
